Emagix is developing generative-AI that addresses a key problem in eye care – the inability of routine eye exams to detect early changes in the function of the eye's blood vessels. This inability leads to delayed diagnosis of eye diseases and puts 500M at risk of vision loss. Emagix’s AI enhances the images eye care professionals routinely capture today, transforming them from static structural data into dynamic functional information that is imperative for early disease detection.